The Roundup – February 15, 2024
View this email in your browser February 15, 2024 Member News A new class of cancer drugs is coming: Pfizer & Arvinas‘ hot pursuit of protein degrader technology...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
View this email in your browser February 15, 2024 Member News A new class of cancer drugs is coming: Pfizer & Arvinas‘ hot pursuit of protein degrader technology...
View this email in your browser February 8, 2024 Member News Arvinas and Pfizer’s Vepdegestrant (ARV-471) receives FDA fast track designation for the treatment of patients with...
View this email in your browser We are thrilled to extend a special invitation to the upcoming Connecticut Rare Disease Forum, hosted by BioCT and The Jackson...
View this email in your browser February 1, 2024 Member News Over 20 CT companies included in America’s Greatest Workplaces for Diversity 2024 (Boehringer Ingelheim, Pfizer)...
View this email in your browser January 25, 2024 BioCT News “Think Big” to continue growth of CT’s life science industry Member News Arvinas appoints...
BioCT event with state and industry leaders focuses on the need for collaboration, workforce growth and supportive policies(New Haven, Conn.) BioCT- the trade organization for...
View this email in your browser January 11, 2024 Four Accomplished Life Science Executives Join Board of Directors Welcome to our new Board members: Jean-Michel Boers, US...
View this email in your browser January 4, 2024 Member News Boehringer Ingelheim partners with Ribo to develop new treatments for people with liver diseases Enko featured...
View this email in your browser December 21, 2023 Member News Alexion leaders talk research, booming biotech industry in New Haven BIO: SCOTUS should preserve FDA’s “mandated...
Innovation is Under ThreatLast Thursday, the Biden Administration released draft guidance outlining proposed factors that an agency may consider, including the “reasonableness of a product’s...